ERBB2 and non-small cell lung carcinoma: Increased HER-2 activity is the assumed mechanism underlying cell cycle control, proliferation, differentiation, motility, apoptosis, metastasis and transformation (14,24–26) and HER-2 overexpression is observed in numerous human carcinomas, including breast, ovarian, gastric, colon and non-small cell lung cancer.